Oragenics, Inc.
(NYSE Amex Equities : OGEN)

... ...
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 4.40%153.470.0%$2825.39m
BNGOBioNano Genomics, Inc. -3.22%12.180.0%$2595.16m
GILDGilead Sciences, Inc. -1.86%66.891.0%$666.78m
AMGNAmgen, Inc. -0.12%256.791.3%$583.98m
REGNRegeneron Pharmaceuticals, Inc. -0.35%546.312.7%$500.51m
ALXNAlexion Pharmaceuticals, Inc. 0.37%161.922.0%$480.78m
CRSPCRISPR Therapeutics AG -4.24%173.560.6%$457.90m
AXONAxovant Sciences Ltd 1.44%177.065.1%$441.74m
ILMNIllumina, Inc. -0.49%418.943.5%$440.59m
NVAXNovavax, Inc. -2.24%128.5192.9%$417.92m
VRTXVertex Pharmaceuticals, Inc. -0.71%239.601.9%$382.27m
SRPTSarepta Therapeutics, Inc. -2.60%93.6113.8%$357.37m
BIIBBiogen, Inc. -2.00%270.031.7%$327.56m
BNTXBioNTech SE -0.82%109.700.0%$312.37m
EXASEXACT Sciences Corp. -7.04%143.1019.6%$249.07m

Company Profile

Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.